Crossmark

Molecularly targeted therapy for extremely rare tumor subtypes

Crossref DOI link: https://doi.org/10.1007/s13691-022-00577-4

Published Online: 2022-09-25

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Matsumura, Noriomi
License Information

Text and Data Mining valid from 2022-09-25

Version of Record valid from 2022-09-25
More Information

Article History

First Online: 25 September 2022

Free to read: This content has been made available to all.